NL-OMON52105招募中不适用
Monitor immune microenvironment and systemic immune effects in pediatric oncology - Mimic study
Prinses Máxima Centrum voor Kinderoncologie0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 至 64（—）
入选标准
- •For Brain tumor arm:
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •- Age 0 - 25 years at inclusion
- •- Newly diagnosed brain tumor or relapse of a brain tumor
- •- MRI representing an image of a brain tumor, not resembling a germcell tumor
- •or a craniopharyngioma
- •- Clinical indication for tumor biopsy/resection
- •- Written (parental) informed consent
- •Healthy controls
- •- Sibling of a patient already participating in the MIMIC brain study
- •- Age 0 - 25 years at inclusion
- •- Written (parental) informed consent
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •Age 0 - 21 years at inclusion
- •Treatment at a Pediatric Cancer Center (Princess Maxima Center for Pediatric
- •Newly diagnosed AML, including relapse of AML that was not previously included
- •at diagnosis
- •Written (parental) informed consent
排除标准
- •For Brain tumor arm:
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •- Suspected germ cell tumor on radiology or based on tumor markers (aFP, βHCG)
- •- Suspected craniopharyngioma on radiology
- •- Not willing to consent
- •For AML arm:
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •- acute myeloid leukemia in children with Down syndrome
- •- acute promyelocytic leukemia
- •- not willing to consent
研究者
相似试验
招募中
不适用
Monitor Immune Microenvironment and systemic immune effects in pediatric Brain tumorsPediatric brain tumorsNL-OMON24486Princess Máxima Center for Pediatric Oncology60
招募中
不适用
Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.Breastcancermammacarcinoma10006291NL-OMON36250Antoni van Leeuwenhoek Ziekenhuis20
已完成
不适用
Cellular & Serological Immune Response Monitoring in SARS-CoV2-infected individuals, without need of hospitalizatioCorona virusCOVID-191004743810024970NL-OMON50071eids Universitair Medisch Centrum10
已完成
不适用
Immunological monitoring and assessment of biomarkers predictive of clinical response to first-line treatment with bosutinib or imatinib in chronic phase chronic myeloid leukemiaChronic myeloid leukemiaCML10024324NL-OMON42791Vrije Universiteit Medisch Centrum5
进行中（未招募）
1 期
Monitoring response on COVID-19 vaccination in children with cancerChildren with cancer, receiving COVID-19 vaccinationEUCTR2021-003388-90-NLPrincess Máxima Center for Pediatric Oncology130